Literature DB >> 10402524

The importance of in situ light dosimetry for photodynamic therapy of oral cavity tumors.

I B Tan1, H Oppelaar, M C Ruevekamp, R B Veenhuizen, A Timmers, F A Stewart.   

Abstract

BACKGROUND: Photodynamic therapy (PDT) is being evaluated for treatment of localized head and neck cancer. "Light dose" is usually prescribed as incident fluence, which takes no account of reflected and scattered light. This study investigates variations in total tissue fluence for a given incident fluence in the oral cavity.
METHODS: Light dosimetry was performed in 19 patients treated with PDT for cancers in the oral cavity and in 5 volunteers. Illumination was with 652 nm laser light delivered via a microlens. In situ dosimetry was performed with isotropic probes held against the tissue in the illuminated area.
RESULTS: Tissue fluences of 254% to 305% of the incident fluence were measured in the illuminated area in healthy volunteers. In the patient population tissue fluences were 133% to 545% of the incident fluence.
CONCLUSION: The relationship between incident and total tissue fluence depended on the location and pigmentation of the target area and was not predictable. In situ dosimetry during cavity illumination allows for more controlled tissue illumination and should be employed as the basis for light dose prescription in PDT for head and neck cancer. Copyright 1999 John Wiley & Sons, Inc. Head Neck 21: 434-441, 1999.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10402524     DOI: 10.1002/(sici)1097-0347(199908)21:5<434::aid-hed9>3.0.co;2-b

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  6 in total

1.  Targeted laryngeal photodynamic therapy with a balloon diffusing light source.

Authors:  Craig Grossman; Timothy Zhu; Jarod Finlay; Andrea Dimofte; Kelly Malloy; Bert O'Malley; Gregory Weinstein; Theresa M Busch; Harry Quon
Journal:  Photodiagnosis Photodyn Ther       Date:  2010-08-03       Impact factor: 3.631

Review 2.  Photodynamic therapy in the management of pre-malignant head and neck mucosal dysplasia and microinvasive carcinoma.

Authors:  Harry Quon; Craig E Grossman; Jarod C Finlay; Timothy C Zhu; Clarice S Clemmens; Kelly M Malloy; Theresa M Busch
Journal:  Photodiagnosis Photodyn Ther       Date:  2011-06       Impact factor: 3.631

3. 

Authors:  C S Betz; A Leunig
Journal:  HNO       Date:  2004-02       Impact factor: 1.284

Review 4.  Photodynamic therapy for treatment of solid tumors--potential and technical challenges.

Authors:  Zheng Huang; Heping Xu; Arlen D Meyers; Ali I Musani; Luowei Wang; Randall Tagg; Al B Barqawi; Yang K Chen
Journal:  Technol Cancer Res Treat       Date:  2008-08

Review 5.  Monitoring photodynamic therapy of head and neck malignancies with optical spectroscopies.

Authors:  Ulas Sunar
Journal:  World J Clin Cases       Date:  2013-06-16       Impact factor: 1.337

Review 6.  Photodynamic therapy for mesothelioma.

Authors:  S M Hahn; R P Smith; J Friedberg
Journal:  Curr Treat Options Oncol       Date:  2001-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.